Delaware | 000-31191 | 04-3324394 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
8 Sylvan Way Parsippany, New Jersey |
07054 | |
(Address of Principal Executive Offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01. | Financial Statements and Exhibits |
(c) | Exhibits | |
The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed: |
99.1 | Press release dated February 16, 2011 |
THE MEDICINES COMPANY |
||||
Date: February 16, 2011 | By: | /s/ Paul M. Antinori | ||
Paul M. Antinori | ||||
Senior Vice President and General Counsel |
Exhibit No. | Description | |||
99.1 | Press release dated February 16, 2011 |